Article
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
1 Jan 1999
Abstract excerpt
Fomivirsen is a 21-nucleotide phosphorothioate oligonucleotide which, when injected into a human eye, is capable of inhibiting CMV retinitis. Its mode of action is consistent with an antisense mechanism. Prior to human trials, fomivirsen was tested in a number of in vitro cell lines and was found to inhibit CMV replication in a dose-dependent manner with a mean 50% inhibitory concentration between 0.03 and 0.2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
